Garlic Supplement Dissolution Standards Clinical Trial Use Suggested
This article was originally published in The Tan Sheet
Future clinical trials on garlic and cardiovascular disease should use supplements that pass U.S. Pharmacopeia dissolution standards for high allicin release, a researcher suggested at a National Institutes of Health conference June 12 in Bethesda, Md.
You may also be interested in...
Clinical studies examining the efficacy of different garlic formulations at comparable doses "would help determine whether garlic has a specific effect on cholesterol levels," researchers conclude in a meta-analysis appearing in the Sept. 19 Annals of Internal Medicine.
The effect of garlic on cardiovascular disease and cancer prevention and Silybum marianum (milk thistle) on liver disease is being investigated by the University of Texas Health Science Center, San Antonio, under a grant from HHS' Agency for Health Care Policy & Research.
Perrigo promotes in pricing, planning